Laviv (autologous fibroblast cell therapy system) - Precigen, Paragon Biosci
Fibrocell Science: Rodman & Renshaw Global Investment Conference (Fibrocell Science) - Sep 12, 2013 - Anticipated initiation of P2 trial for burn scars in H2 2013; Anticipated publication of primary data from P2 trial for burn scars in H2 2014; Anticipated initiation of P3 trial for burn scars in H1 2015; Anticipated publication of data from P3 trial for burn scars in H1 2016; Anticipated initiation of P2 trial for vocal fold scars in H2 2013; Anticipated publication of primary data from P2 trial for vocal fold scars in H2 2014; Anticipated initiation of P3 trial for vocal fold scars in H1 2015; Anticipated publication of data from P3 trial for vocal fold scars in H1 2016 
Anticipated P2 data • Anticipated P3 data • Anticipated trial initiation date Fibrosis
http://www.fibrocellscience.com/wp-content/uploads/2011/08/FCSC-Investor_Presentation-Sep_2013.pdf
 
Sep 12, 2013
 
.
 
01a63317-ae6a-4d63-84e0-d4d39f38a5c7.jpg